Literature DB >> 25247408

Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease.

An Tang1, Ajinkya Desai, Gavin Hamilton, Tanya Wolfson, Anthony Gamst, Jessica Lam, Lisa Clark, Jonathan Hooker, Tanya Chavez, Brandon D Ang, Michael S Middleton, Michael Peterson, Rohit Loomba, Claude B Sirlin.   

Abstract

PURPOSE: To evaluate the diagnostic performance of previously proposed high-specificity magnetic resonance (MR) imaging-estimated proton density fat fraction (PDFF) thresholds for diagnosis of steatosis grade 1 or higher (PDFF threshold of 6.4%), grade 2 or higher (PDFF threshold of 17.4%), and grade 3 (PDFF threshold of 22.1%) by using histologic findings as a reference in an independent cohort of adults known to have or suspected of having nonalcoholic fatty liver disease (NAFLD).
MATERIALS AND METHODS: This prospective, cross-sectional, institutional review board-approved, HIPAA-compliant single-center study was conducted in an independent cohort of 89 adults known to have or suspected of having NAFLD who underwent contemporaneous liver biopsy. MR imaging PDFF was estimated at 3 T by using magnitude-based low-flip-angle multiecho gradient-recalled-echo imaging with T2* correction and multipeak modeling. Steatosis was graded histologically (grades 0, 1, 2, and 3, according to the Nonalcoholic Steatohepatitis Clinical Research Network scoring system). Sensitivity, specificity, and binomial confidence intervals were calculated for the proposed MR imaging PDFF thresholds.
RESULTS: The proposed MR imaging PDFF threshold of 6.4% to diagnose grade 1 or higher steatosis had 86% sensitivity (71 of 83 patients; 95% confidence interval [CI]: 76, 92) and 83% specificity (five of six patients; 95% CI: 36, 100). The threshold of 17.4% to diagnose grade 2 or higher steatosis had 64% sensitivity (28 of 44 patients; 95% CI: 48, 78) and 96% specificity (43 of 45 patients; 95% CI: 85, 100). The threshold of 22.1% to diagnose grade 3 steatosis had 71% sensitivity (10 of 14 patients; 95% CI: 42, 92) and 92% specificity (69 of 75 patients; 95% CI: 83, 97).
CONCLUSION: In an independent cohort of adults known to have or suspected of having NAFLD, the previously proposed MR imaging PDFF thresholds provided moderate to high sensitivity and high specificity for diagnosis of grade 1 or higher, grade 2 or higher, and grade 3 steatosis. Prospective multicenter studies are now needed to further validate these high-specificity thresholds. © RSNA, 2014.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25247408      PMCID: PMC4314291          DOI: 10.1148/radiol.14140754

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  52 in total

Review 1.  Liver biopsy.

Authors:  A A Bravo; S G Sheth; S Chopra
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

3.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.

Authors:  Arie Regev; Mariana Berho; Lennox J Jeffers; Clara Milikowski; Enrique G Molina; Nikolaos T Pyrsopoulos; Zheng-Zhou Feng; K Rajender Reddy; Eugene R Schiff
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

4.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors:  C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

5.  Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

Authors:  Vlad Ratziu; Frédéric Charlotte; Agnès Heurtier; Sophie Gombert; Philippe Giral; Eric Bruckert; André Grimaldi; Frédérique Capron; Thierry Poynard
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

6.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

7.  The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.

Authors:  Leon A Adams; Schuyler Sanderson; Keith D Lindor; Paul Angulo
Journal:  J Hepatol       Date:  2005-01       Impact factor: 25.083

8.  Assessment of donor liver steatosis: pathologist or automated software?

Authors:  Hendrik Marsman; Takakazu Matsushita; Ross Dierkhising; Walter Kremers; Charles Rosen; Lawrence Burgart; Scott L Nyberg
Journal:  Hum Pathol       Date:  2004-04       Impact factor: 3.466

9.  Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.

Authors:  Terry Gramlich; David E Kleiner; Arthur J McCullough; Christi A Matteoni; Navdeep Boparai; Zobair M Younossi
Journal:  Hum Pathol       Date:  2004-02       Impact factor: 3.466

10.  Sampling variability of liver fibrosis in chronic hepatitis C.

Authors:  Pierre Bedossa; Delphine Dargère; Valerie Paradis
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

View more
  89 in total

1.  Proton density fat fraction (PDFF) MRI for differentiation of benign and malignant vertebral lesions.

Authors:  Frederic Carsten Schmeel; Julian Alexander Luetkens; Peter Johannes Wagenhäuser; Michael Meier-Schroers; Daniel Lloyd Kuetting; Andreas Feißt; Jürgen Gieseke; Leonard Christopher Schmeel; Frank Träber; Hans Heinz Schild; Guido Matthias Kukuk
Journal:  Eur Radiol       Date:  2018-01-08       Impact factor: 5.315

2.  A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.

Authors:  Jeremy S Paige; Gregory S Bernstein; Elhamy Heba; Eduardo A C Costa; Marilia Fereirra; Tanya Wolfson; Anthony C Gamst; Mark A Valasek; Grace Y Lin; Aiguo Han; John W Erdman; William D O'Brien; Michael P Andre; Rohit Loomba; Claude B Sirlin
Journal:  AJR Am J Roentgenol       Date:  2017-03-07       Impact factor: 3.959

3.  Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range.

Authors:  Charlie C Park; Catherine Hooker; Jonathan C Hooker; Emily Bass; William Haufe; Alexandra Schlein; Yesenia Covarrubias; Elhamy Heba; Mark Bydder; Tanya Wolfson; Anthony Gamst; Rohit Loomba; Jeffrey Schwimmer; Diego Hernando; Scott B Reeder; Michael Middleton; Claude B Sirlin; Gavin Hamilton
Journal:  J Magn Reson Imaging       Date:  2018-04-29       Impact factor: 4.813

4.  Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease.

Authors:  Veeral H Ajmera; Amy Liu; Seema Singh; Georg Yachoa; Matthew Ramey; Meera Bhargava; Ava Zamani; Scarlett Lopez; Neeraj Mangla; Ricki Bettencourt; Emily Rizo; Mark Valasek; Cynthia Behling; Lisa Richards; Claude Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2020-01-27       Impact factor: 17.425

5.  Quantitative ultrasound and machine learning for assessment of steatohepatitis in a rat model.

Authors:  An Tang; François Destrempes; Siavash Kazemirad; Julian Garcia-Duitama; Bich N Nguyen; Guy Cloutier
Journal:  Eur Radiol       Date:  2018-12-17       Impact factor: 5.315

6.  Evaluation of six-point modified dixon and magnetic resonance spectroscopy for fat quantification: a fat-water-iron phantom study.

Authors:  Kei Fukuzawa; Tatsuya Hayashi; Junji Takahashi; Chiharu Yoshihara; Masakatsu Tano; Jun'ichi Kotoku; Satoshi Saitoh
Journal:  Radiol Phys Technol       Date:  2017-08-02

7.  How bariatric surgery affects liver volume and fat density in NAFLD patients.

Authors:  Ran B Luo; Toshiaki Suzuki; Jonathan C Hooker; Yesenia Covarrubias; Alexandra Schlein; Shanglei Liu; Jeffrey B Schwimmer; Scott B Reeder; Luke M Funk; Jacob A Greenberg; Guilherme M Campos; Bryan J Sandler; Santiago Horgan; Claude B Sirlin; Garth R Jacobsen
Journal:  Surg Endosc       Date:  2017-12-07       Impact factor: 4.584

Review 8.  Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging.

Authors:  Yingzhen N Zhang; Kathryn J Fowler; Gavin Hamilton; Jennifer Y Cui; Ethan Z Sy; Michelle Balanay; Jonathan C Hooker; Nikolaus Szeverenyi; Claude B Sirlin
Journal:  Br J Radiol       Date:  2018-06-06       Impact factor: 3.039

9.  Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI.

Authors:  Scott M Thompson; Ishan Garg; Eric C Ehman; Shannon P Sheedy; Candice A Bookwalter; Rickey E Carter; Lewis R Roberts; Sudhakar K Venkatesh
Journal:  Br J Radiol       Date:  2018-08-29       Impact factor: 3.039

Review 10.  [Functional MR imaging of the liver].

Authors:  A Wibmer; R Nolz; M Trauner; A Ba-Ssalamah
Journal:  Radiologe       Date:  2015-12       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.